Alkermes (NASDAQ: ALKS) VP exercises RSUs and withholds shares for taxes

Rhea-AI Filing Summary

Alkermes plc VP, Finance (Interim PAO) Samuel Joseph Parisi reported equity award transactions involving restricted stock units (RSUs) and ordinary shares. On February 18 and 19, 2026, RSU awards were exercised, converting 2,034 and 2,991 RSUs into the same number of ordinary shares at a price of $0.00 per share.

To cover tax obligations, Parisi disposed of 706 ordinary shares at $32.02 and 979 ordinary shares at $32.00 through share withholding transactions coded "F," which are described as payments of tax liability by delivering securities. After these transactions, he directly held 11,057 ordinary shares. Footnotes state that each RSU represents a right to one ordinary share, that one award is fully vested, and another vests in four equal annual installments starting on February 19, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parisi Samuel Joseph

(Last) (First) (Middle)

900 WINTER STREET

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alkermes plc. [ ALKS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Finance (Interim PAO)

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	02/18/2026		M		2,034	A	(1)	9,751	D
Ordinary Shares	02/18/2026		F		706	D	$32.02	9,045	D
Ordinary Shares	02/19/2026		M		2,991	A	(1)	12,036	D
Ordinary Shares	02/19/2026		F		979	D	$32	11,057	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit Award	(1)	02/18/2026		M			2,034	(2)	(2)	Ordinary Shares	2,034	(1)	0	D
Restricted Stock Unit Award	(1)	02/19/2026		M			2,991	(3)	(3)	Ordinary Shares	2,991	(1)	8,974	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one ordinary share.

2. This award is fully vested in accordance with its terms.

3. Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026.

	/s/ Shantale Greenson, attorney-in-fact for Samuel Joseph Parisi	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Alkermes (ALKS) executive Samuel Joseph Parisi report?

Samuel Joseph Parisi reported RSU exercises and related share withholding. He converted 2,034 and 2,991 restricted stock units into ordinary shares at $0.00 per share and had shares withheld to satisfy tax liabilities, ending with direct ownership of 11,057 ordinary shares.

How many Alkermes (ALKS) shares did Samuel Joseph Parisi acquire through RSU exercises?

Parisi acquired 2,034 and 2,991 Alkermes ordinary shares through RSU exercises. Each restricted stock unit represents a right to receive one ordinary share, and these derivative exercises were coded "M" for the exercise or conversion of derivative securities.

What were the tax withholding share dispositions in the Alkermes (ALKS) Form 4?

The Form 4 shows dispositions of 706 and 979 ordinary shares coded "F". This code indicates payment of exercise price or tax liability by delivering securities, with the shares valued at $32.02 and $32.00 per share, respectively, rather than open-market selling.

How many Alkermes (ALKS) ordinary shares does Samuel Joseph Parisi hold after these transactions?

After the reported transactions, Parisi directly holds 11,057 Alkermes ordinary shares. This figure comes from the share balance listed as "total shares following transaction" for his final ordinary share entry in the Form 4’s non-derivative transaction table.

What do the Alkermes (ALKS) RSU footnotes say about vesting for Samuel Joseph Parisi?

The footnotes state each RSU equals one ordinary share, one award is fully vested, and another award vests in four equal annual installments. Those installments are scheduled to begin on February 19, 2026, providing a multi‑year vesting timeline for that grant.

Is Samuel Joseph Parisi’s Alkermes (ALKS) Form 4 a routine equity compensation event?

The transactions reflect RSU exercises at $0.00 per share and share withholding for taxes, a common equity compensation pattern. They are tied to restricted stock unit awards and do not show open‑market purchases or sales by Alkermes’ VP, Finance (Interim PAO).